Jacobs & Co’s Johnson & Johnson JNJ Stock Holding History

Jacobs & Co’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.4M	Sell	48,675 -32	-0.1%	-$7.46K	1.06%	31
2026 Q1	$11.9M	Sell	48,707 -611	-1%	-$142K	1.18%	31
2025 Q4	$10.2M	Sell	49,318 -2,321	-4%	-$459K	0.96%	40
2025 Q3	$9.57M	Sell	51,639 -481	-0.9%	-$82.4K	0.92%	43
2025 Q2	$7.96M	Sell	52,120 -2,195	-4%	-$337K	0.79%	55
2025 Q1	$9.01M	Sell	54,315 -2,254	-4%	-$353K	0.96%	45
2024 Q4	$8.18M	Buy	56,569 +179	+0.3%	+$27.7K	0.83%	50
2024 Q3	$9.14M	Sell	56,390 -884	-2%	-$141K	0.91%	45
2024 Q2	$8.37M	Buy	57,274 +1,395	+2%	+$207K	0.88%	48
2024 Q1	$8.84M	Buy	55,879 +1,017	+2%	+$162K	0.94%	48
2023 Q4	$8.6M	Buy	54,862 +1,924	+4%	+$295K	0.98%	43
2023 Q3	$8.24M	Sell	52,938 -9,059	-15%	-$1.49M	1.03%	43
2023 Q2	$10.3M	Buy	61,997 +308	+0.5%	+$49.7K	1.22%	35
2023 Q1	$9.56M	Buy	61,689 +1,775	+3%	+$287K	1.18%	39
2022 Q4	$10.6M	Buy	59,914 +2,031	+4%	+$351K	1.38%	29
2022 Q3	$9.46M	Sell	57,883 -745	-1%	-$126K	1.36%	27
2022 Q2	$10.4M	Sell	58,628 -2,919	-5%	-$520K	1.39%	28
2022 Q1	$10.9M	Sell	61,547 -1,009	-2%	-$172K	1.21%	35
2021 Q4	$10.7M	Buy	62,556 +3,884	+7%	+$636K	1.11%	39
2021 Q3	$9.47M	Buy	58,672 +125	+0.2%	+$21.3K	1.09%	41
2021 Q2	$9.64M	Sell	58,547 -1,619	-3%	-$268K	1.11%	37
2021 Q1	$9.89M	Buy	60,166 +571	+1%	+$92.4K	1.21%	34
2020 Q4	$9.38M	Sell	59,595 -1,463	-2%	-$216K	1.22%	28
2020 Q3	$9.09M	Sell	61,058 -308	-0.5%	-$45.6K	1.32%	29
2020 Q2	$8.63M	Sell	61,366 -747	-1%	-$109K	1.4%	25
2020 Q1	$8.14M	Sell	62,113 -92	-0.1%	-$13.1K	1.57%	19
2019 Q4	$9.07M	Buy	62,205 +2,703	+5%	+$367K	1.38%	27
2019 Q3	$7.7M	Sell	59,502 -1,078	-2%	-$142K	1.25%	31
2019 Q2	$8.44M	Buy	60,580 +33	+0.1%	+$4.57K	1.36%	25
2019 Q1	$8.46M	Buy	60,547 +1,947	+3%	+$261K	1.44%	23
2018 Q4	$7.56M	Buy	58,600 +2,523	+4%	+$352K	1.49%	27
2018 Q3	$7.75M	Sell	56,077 -1,979	-3%	-$263K	1.31%	33
2018 Q2	$7.04M	Sell	58,056 -627	-1%	-$78.2K	1.28%	33
2018 Q1	$7.52M	Buy	58,683 +56,182	+2,246%	+$7.59M	1.39%	29
2017 Q4	$267K	Sell	2,501 -320	-11%	-$44.6K	0.05%	115
2017 Q3	$269K	Hold	2,821	–	–	0.05%	111
2017 Q2	$257K	Sell	2,821 -50	-2%	-$6.38K	0.05%	115
2017 Q1	$252K	Sell	2,871 -59,748	-95%	-$7.14M	0.05%	116
2016 Q4	$7.21M	Sell	62,619 -300	-0.5%	-$34.7K	1.56%	20
2016 Q3	$7.43M	Sell	62,919 -129	-0.2%	-$15.7K	1.66%	19
2016 Q2	$7.65M	Sell	63,048 -451	-0.7%	-$51.2K	1.8%	16
2016 Q1	$6.87M	Sell	63,499 -2,403	-4%	-$249K	1.65%	19
2015 Q4	$6.47M	Sell	65,902 -720	-1%	-$72.4K	1.68%	19
2015 Q3	$6.22M	Sell	66,622 -289	-0.4%	-$28K	1.65%	18
2015 Q2	$6.52M	Sell	66,911 -2,200	-3%	-$220K	1.63%	17
2015 Q1	$6.95M	Buy	69,111 +525	+0.8%	+$53.4K	1.76%	13
2014 Q4	$7.17M	Buy	68,586 +854	+1%	+$90K	1.89%	9
2014 Q3	$7.22M	Sell	67,732 -149	-0.2%	-$15.5K	2.04%	8
2014 Q2	$7.1M	Sell	67,881 -1,842	-3%	-$186K	2.06%	8
2014 Q1	$6.85M	Buy	69,723 +7,799	+13%	+$723K	2.12%	7
2013 Q4	$5.67M	Sell	61,924 -149	-0.2%	-$13.7K	1.81%	13
2013 Q3	$5.38M	Sell	62,073 -2,263	-4%	-$203K	1.87%	11
2013 Q2	$5.52M	Buy	+64,336	New	+$5.46M	2%	10

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jacobs & Co's JNJ Position: Q2 2026 in Review

Jacobs & Co reduced its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, selling an estimated $7.46K and leaving 48,675 shares worth $12.4M. The position accounts for 1.06% of the portfolio, ranked #31.

Jacobs & Co first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Jacobs & Co held 48,675 shares of Johnson & Johnson worth $12.4M as of Q2 2026.
Jacobs & Co sold 32 Johnson & Johnson shares in Q2 2026, an estimated $7.46K.
Johnson & Johnson made up 1.06% of Jacobs & Co's portfolio in Q2 2026, its #31 holding.
Jacobs & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.